Annual Interest Expense
N/A
December 31, 2022
Summary
- BVXV annual interest expense is not available.
Performance
BVXV Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Interest Expense
N/A
June 30, 2023
Summary
- BVXV quarterly interest expense is not available.
Performance
BVXV Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
N/A
June 30, 2023
Summary
- BVXV TTM interest expense is not available.
Performance
BVXV TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
BVXV Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
BVXV Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
BiondVax Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $1.73 M(+98.8%) | $1.73 M(-227.3%) |
| Sep 2021 | - | $869.90 K(-8.4%) | -$1.36 M(-36.7%) |
| Jun 2021 | - | $949.40 K(+21.3%) | -$2.14 M(-148.6%) |
| Mar 2021 | - | $782.50 K(-119.8%) | $4.42 M(+20.2%) |
| Dec 2020 | $348.90 K(-91.9%) | -$3.96 M(-4842.6%) | $3.68 M(-39.1%) |
| Sep 2020 | - | $83.50 K(-98.9%) | $6.03 M(-1.5%) |
| Jun 2020 | - | $7.51 M(>+9900.0%) | $6.12 M(-3.8%) |
| Mar 2020 | - | $41.50 K(-102.6%) | $6.36 M(-7.5%) |
| Dec 2019 | $4.31 M(+19.8%) | -$1.60 M(-1029.6%) | $6.88 M(-39.4%) |
| Sep 2019 | - | $172.50 K(-97.8%) | $11.34 M(+1.2%) |
| Jun 2019 | - | $7.75 M(+1290.0%) | $11.21 M(+195.3%) |
| Mar 2019 | - | $557.60 K(-80.5%) | $3.80 M(+3.0%) |
| Dec 2018 | $3.60 M | $2.86 M(+6475.6%) | $3.69 M(-223.6%) |
| Sep 2018 | - | $43.50 K(-87.0%) | -$2.98 M(-1.0%) |
| Jun 2018 | - | $335.40 K(-25.1%) | -$3.01 M(+304.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $447.90 K(-111.8%) | -$744.50 K(-159.3%) |
| Dec 2017 | $0.00(0.0%) | -$3.81 M(<-9900.0%) | $1.26 M(-74.5%) |
| Sep 2017 | - | $12.70 K(-99.5%) | $4.94 M(-1.3%) |
| Jun 2017 | - | $2.61 M(+6.4%) | $5.00 M(+108.6%) |
| Mar 2017 | - | $2.45 M(-1972.0%) | $2.40 M(+3881.6%) |
| Dec 2016 | $0.00 | -$130.80 K(-268.8%) | $60.20 K(-68.5%) |
| Sep 2016 | - | $77.50 K(+4743.8%) | $191.00 K(+66.4%) |
| Jun 2016 | - | $1600.00(-98.6%) | $114.80 K(-82.1%) |
| Mar 2016 | - | $111.90 K(+8507.7%) | $640.20 K(+18.5%) |
| Sep 2015 | - | $1300.00(-99.8%) | $540.20 K(-0.1%) |
| Jun 2015 | - | $527.00 K(+4328.6%) | $540.50 K(+1610.4%) |
| Mar 2015 | - | $11.90 K(+643.8%) | $31.60 K(+49.8%) |
| Sep 2014 | - | $1600.00(-91.2%) | $21.10 K(+8.2%) |
| Jun 2014 | - | $18.10 K(+1192.9%) | $19.50 K(+1292.9%) |
| Mar 2014 | - | $1400.00 | $1400.00 |
FAQ
- What is the all time high annual interest expense for BiondVax Pharmaceuticals?
- What is the all time high quarterly interest expense for BiondVax Pharmaceuticals?
- What is the all time high TTM interest expense for BiondVax Pharmaceuticals?
What is the all time high annual interest expense for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual interest expense is $4.31 M
What is the all time high quarterly interest expense for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly interest expense is $7.75 M
What is the all time high TTM interest expense for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high TTM interest expense is $11.34 M